Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

9.83
+1.4717.58%
Post-market: 9.850.0200+0.20%19:56 EDT
Volume:2.84M
Turnover:27.53M
Market Cap:316.48M
PE:-5.53
High:10.43
Open:8.37
Low:8.37
Close:8.36
Loading ...
Jun 10, 2025

Major Issues Report

Form 8-K - Current report
Jun 04, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 12, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 23, 2024

Correspondence

Form CORRESP - Correspondence
Aug 16, 2024

Major Issues Report

Form 8-K - Current report